Viewing Study NCT05568212

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 11:07 AM

Ignite Modification Date: 2025-12-29 @ 4:26 AM

Study NCT ID: NCT05568212

Status: RECRUITING

Last Update Posted: 2025-12-01

First Post: 2022-06-08

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab

Sponsor: Fondazione Ricerca Traslazionale

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module